These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6127494)
21. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease. Sage JI; Schuh L; Heikkila RE; Duvoisin RC Clin Neuropharmacol; 1988 Feb; 11(1):36-44. PubMed ID: 3349496 [TBL] [Abstract][Full Text] [Related]
22. The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role? Agid Y; Graybiel AM; Ruberg M; Hirsch E; Blin J; Dubois B; Javoy-Agid F Adv Neurol; 1990; 53():83-100. PubMed ID: 1978522 [No Abstract] [Full Text] [Related]
23. [Current approaches in the treatment of Parkinson disease]. Caraceni T; Geminiani G; Tamma F Recenti Prog Med; 1989 Dec; 80(12):686-91. PubMed ID: 2576471 [TBL] [Abstract][Full Text] [Related]
24. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease. Sage JI; Sonsalla PK; McHale DM; Heikkila RE; Duvoisin RC Adv Neurol; 1990; 53():383-6. PubMed ID: 2122646 [No Abstract] [Full Text] [Related]
25. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications. Olanow CW; Obeso JA; Stocchi F Lancet Neurol; 2006 Aug; 5(8):677-87. PubMed ID: 16857573 [TBL] [Abstract][Full Text] [Related]
26. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa]. Mizuno J; Kato S; Watada M; Morita S Masui; 2009 Oct; 58(10):1286-9. PubMed ID: 19860235 [TBL] [Abstract][Full Text] [Related]
27. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies. Mouradian MM; Juncos JL; Fabbrini G; Chase TN Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068 [TBL] [Abstract][Full Text] [Related]
29. [The therapy of wearing-off]. Murata M Nihon Rinsho; 2004 Sep; 62(9):1716-9. PubMed ID: 15462390 [TBL] [Abstract][Full Text] [Related]
30. Three types of akinesia in the progressive course of Parkinson's disease. Narabayashi H Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577 [No Abstract] [Full Text] [Related]
31. Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion. Santos-García D; Macías M; Llaneza M; Grande M; de la Fuente-Fernández R Mov Disord; 2011 Feb; 26(3):558-9. PubMed ID: 20960480 [No Abstract] [Full Text] [Related]
32. Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa. Antonini A; Bondiolotti G; Natuzzi F; Bareggi SR Eur Neuropsychopharmacol; 2010 Oct; 20(10):683-7. PubMed ID: 20570113 [TBL] [Abstract][Full Text] [Related]
34. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Sage JI; Mark MH Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688 [TBL] [Abstract][Full Text] [Related]
35. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease]. Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782 [TBL] [Abstract][Full Text] [Related]
36. [Drug therapy in Parkinson's disease]. van Hilten JJ; Roos RA Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151 [TBL] [Abstract][Full Text] [Related]
37. Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers. Burleigh-Jacobs A; Horak FB; Nutt JG; Obeso JA Mov Disord; 1997 Mar; 12(2):206-15. PubMed ID: 9087979 [TBL] [Abstract][Full Text] [Related]
38. The case for and concerns about continuous dopamine stimulation in Parkinson's disease. Nutt JG J Neural Transm Suppl; 1988; 27():11-5. PubMed ID: 3042908 [TBL] [Abstract][Full Text] [Related]
39. Treatment strategies for extension of levodopa effect. LeWitt PA Neurol Clin; 1992 May; 10(2):511-26. PubMed ID: 1584187 [TBL] [Abstract][Full Text] [Related]